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Abstract 
Background: Glutamate dehydrogenase of malaria parasites (pGDH) is widely used in rapid diagnostic tests for 
malaria. Variation in the pGDH gene among Korean isolates of Plasmodium vivax was analysed, and a recombinant 
pGDH protein was evaluated for use as antigens for the serodiagnosis of vivax malaria.
Methods: Genomic DNA was purified from blood samples of 20 patients and the pGDH gene of P. vivax was 
sequenced. Recombinant protein was prepared to determine the antigenicity of pGDH by enzyme‑linked immuno‑
sorbent assay (ELISA).
Results: Partial sequence analysis of the P. vivax pGDH gene from the 20 Korean isolates showed that an open read‑
ing frame (ORF) of 1410 nucleotides encoded a deduced protein of 470 amino acids. The amino acid and nucleotide 
sequences were conserved among all the Korean isolates. This ORF showed 100% homology with P. vivax strain Sal‑I 
(GenBank accession No. XP_001616617.1). The full ORF (amino acids 39–503), excluding the region before the intron, 
was cloned from isolate P. vivax Bucheon 3 (KJ726751) and subcloned into the expression vector pET28b for transfor‑
mation into Escherichia coli BL21(DE3)pLysS. The expressed recombinant protein had a molecular mass of approxi‑
mately 55 kDa and showed 84.8% sensitivity (39/46 cases) and 97.2% specificity (35/36 cases) in an ELISA. The efficacy 
of recombinant pGDH protein in seroepidemiological studies was also evaluated by ELISA using serum samples 
collected from 876 inhabitants of Gyodong‑myeon, Ganghwa County, Incheon Metropolitan City. Of these samples, 
91 (10.39%) showed a positive reaction with recombinant pGDH protein. Among the antibody‑positive individuals, 13 
(14.29%) had experienced malaria infection during the last 10 years.
Conclusion: The pGDH genes of P. vivax isolates from representative epidemic‑prone areas of South Korea are highly 
conserved. Therefore, pGDH is expected to be a useful antigen in seroepidemiological studies. It was difficult to 
identify the foci of malaria transmission in Gyodong‑myeon based on the patient distribution because of the very low 
parasitaemia of Korean vivax malaria. However, seroepidemiology with recombinant pGDH protein easily identified 
regions with the highest incidence of malaria within the study area. Therefore, recombinant pGDH protein may have a 
useful role in serodiagnosis.
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Background
Microscopic examination is the gold standard method for 
diagnosis of malaria. Despite the simplicity and low cost, 
however, it is not always possible to use this method [1]. 
During the last 20  years, the development of alternative 
diagnostic methods for malaria, such as rapid diagnostic 
tests (RDTs), has made it possible to extend biological diag-
nosis to remote areas that lack advanced medical services. 
RDTs are lateral-flow immunochromatographic tests that 
detect specific malaria antigens. They are rapid and sim-
ple enough to carry out without electricity, specific equip-
ment, or intensive training of personnel [2–4]. Glutamate 
dehydrogenase (GDH), an enzyme involved in urea syn-
thesis, catalyzes the reversible oxidative deamination of 
l-glutamate to form α-ketoglutarate and ammonia, using 
nicotinamide adenine dinucleotide phosphate (NADP(H)) 
or nicotinamide adenine dinucleotide (NAD(H)) as cofactor 
[5]. There are three types of GDH, depending on the cofac-
tor. The enzymes specific for NAD(H) (EC 1.4.1.2) generally 
catalyze the oxidative deamination of l-glutamate (to gen-
erate α-ketoglutarate) and have an alkaline pH optimum, 
whereas the enzymes specific for NADP(H) (EC 1.4.1.4) 
usually carry out the reductive amination of α-ketoglutarate 
(to generate l-glutamate) and have a neutral pH optimum. 
The third type (EC 1.4.1.3), represented by the vertebrate 
GDH enzymes, can use both cofactors for the deamina-
tion of l-glutamate [6]. Plasmodium falciparum contains 
three genes encoding potential parasite glutamate dehy-
drogenase (pGDH) proteins; two are found on chromo-
some 14 (PF14_0164 and PF14_0286, encoding pGDHa and 
pGDHb, respectively) and one is present on chromosome 8 
(PF08_0132, encoding pGDHc) [7, 8]. pGDHa and pGDHb 
are NADP(H) dependent, and the primary sequence of 
pGDHb suggests that the protein is located in the apico-
plast, whereas the localization and cofactor specificity of 
pGDHc cannot be predicted. The presence of multiple 
pGDH proteins is reminiscent of the situation in plants and 
fungi [9–12]. pGDH is considered integral to the parasite’s 
antioxidant machinery and is thought to be a potential drug 
target [8, 13–16]. In recent years, pGDH has been used as 
an antigen for malaria detection.
In this study, variation of the pGDH genes of P. vivax 
isolates from 20 patients living in five malaria epidemic-
prone areas of South Korea was investigated, and a 




Patients with clinically suspected malaria who had 
attended Public Health Centers in Bucheon-si, Gimpo-
si, and Paju-si of Gyeonggi Province, Ganghwa County 
of Incheon Metropolitan City, and Cheorwon County 
of Gangwon Province, South Korea, were examined for 
malaria parasites. Blood was collected from symptomatic 
patients and thin and thick blood smears were prepared 
for microscopic examination. The usefulness of recom-
binant pGDH protein in seroepidemiological studies was 
evaluated using sera collected at Gyondong-myeon, Gang-
hwa County, Incheon Metropolitan City, in December 
2012. The serum samples were stored at −80 °C until use.
Microscopic examination
Thin blood films were prepared to determine the infec-
tivity of blood samples. The blood films were fixed with 
methanol and stained with Giemsa stain diluted with 
buffered water (pH 7.2) to emphasize the parasite inclu-
sions in the red blood cells. The densities of blood-stage 
parasites were estimated by counting the number of 
asexual parasites relative to 200 white blood cells (WBCs) 
and then multiplying the parasite:WBC ratio by 8000 (the 
assumed number of WBCs per microlitre of blood) [3, 
17].
Amplification of the pGDH gene
For amplification of the pGDH gene of P. vivax, 
genomic DNA was extracted from each patient’s whole 
blood using a QIAamp DNA Blood Mini Kit (Qia-
gen, Hilden, Germany). The polymerase chain reac-
tion (PCR) was performed using TaKaRa Ex Taq DNA 
polymerase (Takara, Otsu, Japan), 50  ng of purified 
genomic DNA, and 40 pmol each of forward (PvGDH-
F1: 5′-ATT TTA CCC CTC TCG GCC GTG GCC CTT 
TTC-3′) and reverse primers (PvGDH-R1: 5′-GGC 
GCC GTC GCA CTG CTC GTA GAT GCT CCT-3′) 
for DNA sequence analysis (Figs.  1, 2). The PvGDH-
Fex1 primer (5′-AGC CAT ATG CGC GCC AAG GTG 
CGC GGC GC-3′) with an NdeI restriction enzyme site 
(underlined) and the PvGDH-Rex1 primer (5′-GTG 
CTC GAG CAG GCC GCC CTG CTC CAG GA-3) 
with an XhoI restriction enzyme site (underlined) were 
used to establish the recombinant protein expression 
vector. The total PCR volume was adjusted to 50  μL 
with distilled water. The thermocycling conditions were 
as follows: denaturation at 94  °C for 5  min; 35 cycles 
of 30  s at 94  °C, 60  s at 55  °C, and 90  s at 72  °C; and 
final extension at 72  °C for 5  min. All PCR products 
were analysed on a 1% agarose gel, confirmed under a 
UV transilluminator, and purified with a QIAquick Gel 
Extraction Kit (Qiagen).
DNA sequencing and analysis
For genotyping of the pGDH gene of P. vivax, the PCR 
product of the gene was ligated into a pCR2.1 cloning 
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vector (Invitrogen, Carlsbad, CA, USA) and trans-
formed into E. coli TOP10 cells. Cells containing recom-
binant plasmid were selected on ampicillin-containing 
medium [18]. The transformants were confirmed by 
gel electrophoresis of EcoRI-digested plasmid DNA 
prepared with a plasmid isolation kit (Qiagen) accord-
ing to the manufacturer’s protocol. The pGDH gene 
sequence was determined using the ABI PRISM Big-
Dye Terminator Ready Reaction Cycle Sequencing Kit 
FS (Perkin Elmer, Cambridge, MA, USA) according to 
the manual supplied by the manufacturer. The nucleo-
tide and deduced amino acid sequences were analysed 
using EditSeq and Clustal in the MegAlign program, a 
multiple sequence alignment program in the DNASTAR 
package (DNASTAR, Madison, WI, USA). The inter-
net-based BLAST program of the National Center for 
Biotechnology Information was used to search protein 
databases.
Construction of the pGDH expression vector
For expression of recombinant pGDH in E. coli 
BL21(DE3)pLysS, the pGDH gene was amplified from 
a blood sample that was confirmed to be infected with 
the dormant type of P. vivax. Amplification was per-
formed as described above with PvGDH-Fex1 and 
PvGDH-Rex1, which contain NdeI and XhoI sites at 
their 5′ ends, respectively. The amplified PCR prod-
uct was digested with NdeI and XhoI, purified with a 
QIAquick Gel Extraction Kit, and integrated into the 
NdeI and XhoI sites of the pET28b expression vector 
(Novagen). The resulting plasmid (named pVKtype3) 
was subsequently used for the expression of a pGDH-
(His)6 fusion protein in E. coli. The transformants were 
confirmed both by gel electrophoresis of the plasmid 
DNA after digestion with NdeI and XhoI and by DNA 
sequencing.
Expression and purification of recombinant pGDH
Escherichia coli BL21(DE3)pLysS carrying pVKtype3 was 
grown to the logarithmic phase in Luria broth containing 
50 μg/mL kanamycin, and then expression of the recom-
binant protein was induced by adding 1  mM isopropyl-
1-thio-β-d-galactopyranoside (IPTG) to the culture. 
The pGDH-(His)6 fusion protein was purified by affinity 
chromatography [19]. The purification was performed 
under native conditions according to the supplier’s pro-
tocol (Novagen). After each purification step, the protein 
was analysed by sodium dodecyl sulfate polyacrylamide 
gel electrophoresis (SDS-PAGE) with Coomassie brilliant 
blue staining.
Western blot analysis
The recombinant pGDH-(His)6 fusion protein was sepa-
rated on a 12% SDS-PAGE gel and then transferred to a 
nitrocellulose membrane. After the transfer, the mem-
brane was cut into appropriately sized strips and blocked 
with 5% skim milk in phosphate-buffered saline (PBS) for 
12 h at 4 °C. The membrane was then washed three times 
for 10  min each with 0.15% Tween 20-PBS. The strips 
were allowed to react with serum from a patient with 
malaria or an uninfected patient (diluted 1:100, v/v) for 
4 h and then washed as described above. The membrane 
was subsequently incubated with diluted horseradish 
peroxidase-conjugated goat anti-human IgG secondary 
antibody (1:1000, v/v; Sigma) for 3  h at room tempera-
ture. For color development, a solution containing 0.2% 
diaminobenzidine and 0.02% H2O2-PBS was applied to 
each well [20, 21].
Enzyme‑linked immunosorbent assay
Enzyme-linked immunosorbent assays (ELISAs) were 
used to determine whether the blood samples contained 
antibodies against pGDH antigens of P. vivax. Briefly, 
1 bp 1938 bp
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Fig. 1 Structure of the plasmid (pVpGDH) used for DNA sequence analysis and expression of the Plasmodium vivax parasite glutamate dehydroge‑
nase gene

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 2 Multiple amino acid sequence alignment of parasite glutamate dehydrogenases among Plasmodium species. The deduced amino acid 
sequence of the type strain of Korean P. vivax isolates (Pv Kor, Bucheon strain, GenBank accession No. KJ726751) was aligned with sequences 
from other Plasmodium species. Computer analysis was performed using the multiple sequences alignment program MegAlign. All amino acid 
sequences were obtained from GenBank using BLAST (http://www.ncbi.nlm.nih.gov). Py, P. yoelii yoelii strain 17XNL (XM_719434.1); Pk, P. knowlesi 
strain H (XM_002260680.1); Pf, P. falciparum strain FCC1/HN (AY040586.1); Pch, P. chabaudi chabaudi (XM_738585.1); Pc, P. cynomolgi strain B 
(XM_004224427.1); Pb, P. berghei strain ANKA (XM_673901.1); Pv Sal‑1, P. vivax strain Sal‑1 (XP_001616667)
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capture antigen solution (50 μL, 0.5 μg/mL) with recom-
binant pGDH was placed in a 96-well plate (Corning, 
Lowell, MA, USA) and incubated for 12 h at room tem-
perature (RT). After aspiration of the antigen solution, 
the wells were filled with blocking buffer (1% bovine 
serum albumin, 0.05% Tween 20-PBS) and the plates 
were incubated for 1 h at RT. The wells were washed three 
times with 0.05% Tween 20-PBS, and then human serum 
samples diluted in blocking buffer (1:100, v/v) were added 
to the wells. Four positive and four negative control 
serum samples were also added to each plate. After 2 h of 
incubation at RT, the plates were washed three times with 
0.05% Tween 20-PBS, and then horseradish peroxidase-
conjugated anti-human IgG (1:2000, v/v; Sigma) diluted 
in blocking buffer was added. The plates were incubated 
again for 1 h at RT. The reaction was stopped by washing 
the plates as described above. The color was developed 
by adding 100 µL of the peroxidase substrate 2,2′-azino-
bis(3-ethylbenzothiazoline-6-sulfonic acid) (Kirkegaard 
& Perry Laboratories, Gaithersburg, MD, USA) and incu-
bating the plates for 30  min. Optical density was meas-
ured at 450  nm, and the cutoff value for positivity was 
defined as the mean + 2 standard deviations of the nega-
tive control samples.
Calculation of annual parasite incidence
The annual parasite incidence (API) was calculated as the 
number of malaria-positive patients per 1000 inhabitants 
for each study area, that is, API = (number of microscop-
ically proven malaria cases/population of administrative 
area) × 1000.
Data analysis
Data analyses were performed using GraphPad software 
(GraphPad Software Inc., La Jolla, CA, USA). A two-
tailed t test was performed to examine the significance 
of differences between the malaria patient group and the 
normal group in the ELISA test. One-way ANOVA fol-
lowed by a Kruskal–Wallis test was performed to exam-
ine the significance of differences between parasitaemia 
and optical density of ELISA. Pearson’s correlation analy-
sis was performed to examine the relationship between 
positive rate and API in 2012 and 2013. A P value of 
<0.05 was considered statistically significant.
Results
Sequence variation of Plasmodium vivax pGDH genes 
from Korean isolates
The geographical locations of blood sample collection 
were Ganghwa County (37.31N, 125.33E) of Incheon 
Metropolitan City; Gimpo-si (37.33N, 126.48E), Bucheon-
si (37.29N, 126.46E), and Paju-si (37.88N, 126.76E) of 
Gyeonggi Province; and Cheorwon County (38.10N, 
127.30E) of Gangwon Province. Four blood samples from 
patients infected with indigenous P. vivax were collected 
from each location during 2010–2011. Amplification 
of the pGDH gene from blood genomic DNA yielded a 
product of approximately 1400 bp. After purification, the 
amplified gene fragment was ligated into the pCR2.1 clon-
ing vector (3.9 kb). The plasmid containing the PCR prod-
uct was named pVpGDH (5.3 kb) and was used for DNA 
sequence analysis (Fig. 1). Based on the DNA sequencing 
results, the cloned pGDH gene was 1410 bp (excluding the 
start codon, ATG, and the intron) and encoded 470 amino 
acids, which were deduced using DNASIS.
The amino acid and nucleotide sequences were identical 
to all the Korean isolates (KJ726749–KJ726768). Among 
the isolates, Pv Kor (Pvk), isolated from Bucheon-si, was 
designated as the type strain on the basis of pGDH gene 
sequence analysis. The open reading frame showed 100.0% 
homology with P. vivax strain Sal-I (GenBank accession 
No. XM_001616617.1), 83.0% homology with Plasmodium 
cynomolgi strain B (PCYB_132800, XM_004224305.1), 
78.6% homology with Plasmodium knowlesi strain H 
(PKH_131950, XM_002260679.1), 66.6% homology 
with Plasmodium chabaudi chabaudi (XM_738585.1), 
64.5% homology with Plasmodium berghei strain ANKA 
(XM_673901.1), 58.5% homology with Plasmodium falci-
parum (AF269241.1), and 56.2% homology with Plasmo-
dium yoelii yoelii strain 17XNL (XM_719434.1) (Figs. 2, 3).
Expression of pGDH in Escherichia coli
For generation of the expression plasmid, the P. vivax 
pGDH gene sequence from after the intron to before the 
stop codon was amplified from genomic DNA isolated 
from blood of an infected patient. The amplified DNA 
was digested with NdeI and XhoI and subcloned into the 
same restriction sites of the pET28b expression vector. 
The resulting plasmid, pVKtype3, was used to express 
pGDH fused to a (His)6-tag (Fig.  4a). The recombinant 
plasmid was transformed into E. coli BL21(DE3)pLysS 
and protein expression was induced with IPTG. As evi-
dent on the SDS-PAGE gel, the recombinant pGDH pro-
tein had a molecular mass of about 55 kDa under native 
purification conditions (Fig. 4b).
Antigenicity of the recombinant pGDH protein
The antigenicity of the purified recombinant pGDH pro-
tein was assessed by western blot analysis and ELISA. 
The tested samples contained malaria parasites, as con-
firmed by microscopic examination, but the parasites had 
not been counted. Negative sera were collected from vol-
unteer staff from the Korea National Research Institute 
of Health. All sera of P. vivax-infected patients (n =  X) 
exhibited a positive reaction with pGDH by western blot-
ting, whereas sera from the normal control group (n = 5), 
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who had never been exposed to malaria, tested negative. 
In addition, pGDH did not react with the sera of P. falci-
parum-infected patients (n = 11) (Fig. 5). The antigenicity 
of the recombinant pGDH protein was then evaluated by 
ELISA using a larger number of samples. Thirty-nine of 
the 46 microscopically confirmed malaria-positive serum 
Fig. 3 a Phylogenetic relationships among parasite glutamate dehydrogenases of several species of Plasmodium and b percent identity. The 
deduced amino acid sequence of the type strain of Korean P. vivax isolates (Pvk, Bucheon strain, GenBank accession No. KJ726751) was aligned 
with sequences from other Plasmodium species. Computer analysis was performed using the multiple sequences alignment tool of MegAlign. 
All amino acid sequences were obtained from GenBank using BLAST (http://www.ncbi.nlm.nih.gov). Pb, P. berghei strain ANKA (XM_673901.1); 
Pc1, P. cynomologi strain B (PCYB_132800, XM_004224305.1); Pc2, P. cynomolgi strain B (PCYB_134020, XM_004224427.1); Pch, P. chabaudi 
chabaudi (XM_738585.1); Pf1, P. falciparum (AF269241.1); Pf2, P. falciparum strain FCC1/HN (AY040586.1); Pk1, P. knowlesi strain H (PKH_131960, 
XM_002260680.1); Pk2, P. knowlesi strain H (PKH_131950, XM_002260679.1); Pv Sal‑1, P. vivax strain Sal‑1 (XM_001616617.1); Py, P. yoelii yoelii strain 
17XNL (XM_719434.1)
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samples reacted with the recombinant pGDH protein 
(sensitivity of 84.8%). Only 1 of the 36 samples from the 
normal control group reacted with the recombinant pro-
tein (specificity of 97.2%, Fig.  6a). Positive and negative 
sera could be differentiated from 1:80 (v/v) serum dilu-
tion (Fig. 6b). Parasitaemia decreased the intensity of the 
reaction, but the difference was not significant (Fig.  7, 
P = 0.6309).
Usefulness of recombinant pGDH protein 
in seroepidemiology
The usefulness of the purified recombinant pGDH pro-
tein was evaluated by ELISA with the serum samples col-
lected from Gyodong-myeon, Ganghwa County, Incheon 
Metropolitan City, in 2012. A total of 876 serum samples 
(28.49%) were collected from 3074 inhabitants of 13 vil-
lages in Gyodong-myeon (Fig.  8). Ninety-one samples 
(10.39%) were positive in the ELISA. Nanjeong-ri showed 
the highest positive rate (16.81%, 19/113), followed by 
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Fig. 4 a Conformation of the cloned pET28b vector containing the Plasmodium vivax parasite glutamate dehydrogenase (pGDH) gene (pVKtype3). 
M, molecular size marker; lane 1 undigested plasmid; lane 2 NdeI‑digested plasmid; lane 3 NdeI‑ and XhoI‑digested plasmid. b Expression of the 
pGDH gene in Escherichia coli BL21(DE3)pLysS. Lane M molecular weight protein marker; lane 1, Non‑induction clone, lanes 2–4 induction clones of 
recombinant pGDH protein. c Purification of the pGDH protein from Escherichia coli BL21(DE3)pLysS. Lane M molecular weight protein marker; lane 
1 purified recombinant pGDH protein
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Fig. 5 Western blot analysis of recombinant Plasmodium vivax 
parasite glutamate dehydrogenase. a Pv patients (Plasmodium vivax‑
infected patients). b Normal, healthy volunteers. c Pf patients (Plas-
modium falciparum‑infected patients). M molecular weight marker
Page 8 of 11Seol et al. Malar J  (2017) 16:3 
found in Seohan-ri (2.60%, 2/77) (Fig. 8; Table 1). Among 
the antibody-positive individuals, 13 (14.29%) had expe-
rienced malaria infection during the last 10 years, while 
78 (85.71%) had newly acquired antibodies against 
pGDH. Among the 876 inhabitants, 49 (5.59%) had 
experienced malaria infection. Nine malaria cases were 
reported in 2012 and four were reported in 2013; there-
fore, the API was reduced from 2.93 in 2012 to 1.30 in 
2013. Jiseok-ri showed the highest API in 2012 (9.66), 
in accordance with its high positive rate (16.39%), but 
the API decreased to 0 in 2013. Nanjeong-ri showed the 
next highest API in 2012 (7.58), in agreement with its 
high positive rate (16.81%) in comparison with other vil-
lages. Only two villages, Najeong-ri and Samseon-ri, had 
the API in both years, while the APIs of the other vil-
lages were up and down between years. The relationship 
between the pGDH-positive rate and API was stronger in 
2013 than in 2012, although the difference was not sig-
nificant (Table 1).
Discussion
pGDH is a target malaria antigen that is widely used to 
develop monoclonal antibodies for non-microscopic 
immunochromatographic assays (i.e., RDTs). However, 
little is known about the ability to detect antibodies to 
pGDH in serum of patients with malaria. Therefore, the 
sequence variation of pGDH and its antigenicity was 
investigated among Korean isolates.
Plasmodium vivax has been prevalent in Korea for a 
long time. However, as the result of a national malaria 
eradication programme and with help from the World 
Health Organization, the incidence of vivax malaria rap-
idly decreased during the 1960s and 1970s [22–25]. Fol-
lowing the report of two cases of malaria in 1985 [25], 
there were no additional reported cases in Korea until 
the emergence of one case in 1993 [26] and two cases in 
1994 [27]. The incidence of malaria then increased rap-
idly until approximately 2000 [28]. After that, reported 
cases of malaria declined again for several years, owing 
to nationwide efforts to reduce the incidence of this dis-
ease. However, malaria has not been eradicated from the 
Korean peninsula because many travellers and work-
ers come from areas where malaria is prevalent, includ-
ing North Korea [29]. For these reasons, serological 
diagnostic tools are needed to support both traditional 
microscopic diagnosis and antibody testing on a popula-
tion level to gain an estimate of exposure to malaria in 
Korea. Currently, the immunofluorescence antibody test 
(IFAT) is used as the standard serological diagnostic 
method owing to its high sensitivity. However, the sensi-
tivity of this test can be affected by the training and abil-
ity of users [30–32]. Therefore, a new antigen is needed 
for serodiagnosis. Several recombinant proteins cloned 
from Korean isolates of P. vivax have been tested for use 
as antigens for serodiagnosis, including Circumsporo-






























































Fig. 6 Enzyme‑linked immunosorbent assay of immune responses of the vivax malaria patient group and normal individuals to recombinant para‑
site glutamate dehydrogenase (a). Twofold serum dilution of malaria patients (P1–P5) and normal person (N1–N4) (b)
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merozoite surface protein (MSP) [34], CSP and MSP chi-
meric proteins [35], aldolase [36], and parasite lactate 
dehydrogenase [37]. None of these antigens has enabled 
replacement of the IFAT method because of their com-
paratively low sensitivity. Therefore, there has been a 
focus on pGDH. Monoclonal antibodies against pGDH 
have been used in several RDTs and exhibit a relatively 
high sensitivity for detection of malaria parasites. How-
ever, in the present study the ELISA detected only 84.8% 
(39/46) of microscopy-positive samples, even though the 
pGDH gene was cloned from a Korean P. vivax strain 
(pVKtype3, Fig.  2). Therefore, antibody detection using 
the recombinant pGDH protein is not superior to anti-
gen detection using monoclonal antibodies against 
pGDH. Nevertheless, it was worth investigating whether 
the recombinant pGDH protein could be used to detect 
antibodies in asymptomatic patients or symptomatic 
patients with low parasitaemia (under 50/µL), using anti-
body detection methods such as ELISA or western blot-
ting. The recombinant pGDH protein was evaluated for 
its usefulness in seroepidemiology using sera collected 
from Gyodong-myeon, Ganghwa County, Incheon Met-
ropolitan City, in 2012. This study area is an island con-
sisting of several hills surrounded by rice fields and two 
large irrigation reservoirs. Serum samples from 28.74% 
of the inhabitants of this island (876 cases) were tested 
by ELISA with recombinant pGDH protein as antigen. 
The villages with a positive rate above 10% are adjacent 
to the main rice field located in the center of the island 
and the two irrigation reservoirs, which are potential 
habitats for anopheline mosquitoes. In contrast, villages 
with a low positive rate are located in coastal areas and 
are separated by a hill from the main rice field and the 






































































Fig. 8 Seroepidemiological study areas of Gyodong‑myeon, Ganghwa County, Incheon Metropolitan City. A Bongso‑ri; B Gogu‑ri; C Insa‑ri; D Jiseok‑
ri; E Muhak‑ri; F Nanjeong‑ri; G Seohan‑ri; H Dongsan‑ri; I Yanggap‑ri; J Samseon‑ri; K Daeryong‑ri; L Eumnae‑ri; M Sangyong‑ri. DMZ demilitarized 
zone; DPRK Democratic People’s Republic of Korea; ROK Republic of Korea
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study indicate that antibody detection using recombinant 
pGDH may provide useful information regarding the 
prevalence of malaria in certain areas and individuals.
Conclusion
The findings of the present study suggest that seroepi-
demiological studies with recombinant pGDH protein, 
which displayed no amino acid sequence variation among 
20 investigated Korean isolates, may be useful for under-
standing the epidemiology of malaria in Korea.
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